Quantcast
Channel: Videos – Cancer Genetics Inc.
Browsing all 19 articles
Browse latest View live

$CGIX Featured on BusinessTV

Cancer Genetics Inc. (CGIX:NASDAQ) – an emerging leader in DNA-based cancer diagnostics, has created tests that target difficult to diagnose cancers.

View Article



CGIX Analyst Day: Company and Portfolio Updates

Cancer Genetics Inc. September 2014 Company and Portfolio Update CEO Panna Sharma provides introductory remarks. Dr. Gianrico Farrugia, Director of the Center for Individualized Medicine, Mayo Clinic,...

View Article

Focus::NGS™ – Access the Next-Generation of Cancer Diagnostics

Focus::NGS – CGI’s Unique, Targeted NGS Panel One of the major challenges in doing cancer diagnostics is to find mutations that might be very important, but might be present in very low levels in the...

View Article

CGI’s ExpandDx Collaborative Oncology Testing

More than 80% of cancers are diagnosed in community based hospitals and clinics, but many of these facilities don’t have the resources to provide the most advanced testing services. By performing the...

View Article

New Jersey Viewpoint – March 15, 2015

Jane Houldsworth, Ph.D. and Deniliz Rodgriguez discuss how Cancer Genetics is helping to deliver personalized medicine and reflect on their own battles with cancer.

View Article


Cancer Genetics, a global partner for biopharma companies

Panna Sharma, CEO of Cancer Genetics, Inc. speaks about Cancer genetics, a global partner for biopharma companies Globally cancer is increasing significantly and with that increase comes more...

View Article

Predicting response, improving patient outcome

Scott Clark, VP of Global Scientific Operations speaks about Cancer Genetics’ PGx services and how CGI is at the forefront of personalized medicine. Individuals respond differently to medications based...

View Article

Cancer Genetics offers an integrated solution for Clinical Trials.

Nathan Campbell, Director of Clinical Services speaks about Cancer Genetics’ Biorepository capability and how having access to samples genomic data is important. As a clinical trial progresses and a...

View Article


Cancer Genetics offers an integrated solution for clinical trials.

Kristen Hopp, PMP, Senior Clinical Trial Project Associate speaks about Cancer Genetics integrated clinical trial services. In hematological malignancies one of the challenges is the diversity of...

View Article


Cancer Genetics is a center of excellence for oncology-focused clinical trials.

Narasimha Marella, Ph.D., Corporate Development Manager speaks about how Cancer Genetics can help biopharma companies overcome oncology-focused clinical trial challenges. The current challenge that is...

View Article

Cancer Genetics offers the FDA-approved DAKO PD-L1 IHC 22C3 pharmDx companion...

The FDA approved PD-L1 (IHC) 22C3 pharmDx companion diagnostic test for  KEYTRUDA® (pembrolizumab)​ is now available at CGI to assess PD-L1 expression in Non-Small Cell Lung Cancer

View Article

CGIX Analyst Day: Company and Portfolio Updates

Cancer Genetics Inc. September 2014 Company and Portfolio Update CEO Panna Sharma provides introductory remarks. Dr. Gianrico Farrugia, Director of the Center for Individualized Medicine, Mayo Clinic,...

View Article

New Jersey Viewpoint – March 15, 2015

Jane Houldsworth, Ph.D. and Deniliz Rodgriguez discuss how Cancer Genetics is helping to deliver personalized medicine and reflect on their own battles with cancer.

View Article


Cancer Genetics, a global partner for biopharma companies

Panna Sharma, CEO of Cancer Genetics, Inc. speaks about Cancer genetics, a global partner for biopharma companies Globally cancer is increasing significantly and with that increase comes more...

View Article

Predicting response, improving patient outcome

Scott Clark, VP of Global Scientific Operations speaks about Cancer Genetics’ PGx services and how CGI is at the forefront of personalized medicine. Individuals respond differently to medications based...

View Article


Cancer Genetics offers an integrated solution for Clinical Trials.

Nathan Campbell, Director of Clinical Services speaks about Cancer Genetics’ Biorepository capability and how having access to samples genomic data is important. As a clinical trial progresses and a...

View Article

Cancer Genetics offers an integrated solution for clinical trials.

Kristen Hopp, PMP, Senior Clinical Trial Project Associate speaks about Cancer Genetics integrated clinical trial services. In hematological malignancies one of the challenges is the diversity of...

View Article


Cancer Genetics is a center of excellence for oncology-focused clinical trials.

Narasimha Marella, Ph.D., Corporate Development Manager speaks about how Cancer Genetics can help biopharma companies overcome oncology-focused clinical trial challenges. The current challenge that is...

View Article

Cancer Genetics offers the FDA-approved DAKO PD-L1 IHC 22C3 pharmDx companion...

The FDA approved PD-L1 (IHC) 22C3 pharmDx companion diagnostic test for  KEYTRUDA® (pembrolizumab)​ is now available at CGI to assess PD-L1 expression in Non-Small Cell Lung Cancer

View Article
Browsing all 19 articles
Browse latest View live




Latest Images